Received Dec 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 946915 | IM / LA |
Patient did not experience a side effect from the vaccine. It was discovered that patient inappropriately received their second dose of heplisav too soon following their first dose. the second dose was given at day 11 instead of 28 days following the initial dose.
unknown
unknown
unknown
no known allergies
none at this time.